State Street’s Boundless Bio BOLD Stock Holding History

State Street’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.9K	Hold	15,962	–	–	﹤0.01%	4085
2026 Q1	$17.6K	Hold	15,962	–	–	﹤0.01%	4221
2025 Q4	$19.2K	Hold	15,962	–	–	﹤0.01%	4245
2025 Q3	$19.6K	Hold	15,962	–	–	﹤0.01%	4247
2025 Q2	$16.1K	Sell	15,962 -32,224	-67%	-$42.8K	﹤0.01%	4215
2025 Q1	$72.8K	Buy	48,186 +4,109	+9%	+$8.52K	﹤0.01%	4031
2024 Q4	$128K	Buy	44,077 +18,712	+74%	+$54.5K	﹤0.01%	3943
2024 Q3	$88K	Buy	25,365 +4,100	+19%	+$14.9K	﹤0.01%	4001
2024 Q2	$82.3K	Buy	+21,265	New	+$203K	﹤0.01%	4055

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street's BOLD Position: Q2 2026 in Review

State Street held its Boundless Bio (BOLD) position steady in Q2 2026 at 15,962 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

State Street first reported a position in BOLD in Q2 2024 and has held it in 9 quarters since. The position peaked at $128K in Q4 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

State Street held 15,962 shares of Boundless Bio worth $39.9K as of Q2 2026.
State Street left its Boundless Bio share count unchanged in Q2 2026.
Boundless Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4085 holding.
State Street first reported a position in Boundless Bio in Q2 2024 and has held it in 9 quarters since.
State Street's Boundless Bio position peaked at $128K in Q4 2024.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.